Home › Leukemia
Pag-aaral pangklinika para sa Leukemia na nagre-recruit sa U.S.
102 pag-aaral para sa Leukemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX28 pag-aaral
- Boston, MA25 pag-aaral
- New York City, NY19 pag-aaral
- Chicago, IL16 pag-aaral
- Los Angeles, CA16 pag-aaral
- Durham, NC13 pag-aaral
- Philadelphia, PA12 pag-aaral
- Columbus, OH12 pag-aaral
- Nashville, TN12 pag-aaral
- Baldwin Park, CA12 pag-aaral
- Milwaukee, WI11 pag-aaral
- Seattle, WA11 pag-aaral
- Aurora, CO10 pag-aaral
- Atlanta, GA10 pag-aaral
- Birmingham, AL10 pag-aaral
- Cincinnati, OH9 pag-aaral
- Edison, NJ9 pag-aaral
- Mountain View, CA9 pag-aaral
- Miami, FL9 pag-aaral
- New Haven, CT8 pag-aaral
- Dallas, TX8 pag-aaral
- Queens, NY8 pag-aaral
- Portland, OR8 pag-aaral
- Denver, CO7 pag-aaral
- Clifton, NJ7 pag-aaral
- Orange, CA7 pag-aaral
- Buffalo, NY7 pag-aaral
- Washington, DC7 pag-aaral
- Tampa, FL7 pag-aaral
- Omaha, NE6 pag-aaral
- Cedar Rapids, IA6 pag-aaral
- San Diego, CA5 pag-aaral
- Ann Arbor, MI5 pag-aaral
- Cleveland, OH5 pag-aaral
- Baltimore, MD5 pag-aaral
- Rochester, MN5 pag-aaral
- Charlottesville, VA5 pag-aaral
- Charlotte, NC5 pag-aaral
- Memphis, TN5 pag-aaral
- Akron, OH4 pag-aaral
Ayos sa estado
- Alabama10 pag-aaral
- Arizona7 pag-aaral
- California28 pag-aaral
- Colorado15 pag-aaral
- Connecticut11 pag-aaral
- Florida17 pag-aaral
- Georgia12 pag-aaral
- Illinois17 pag-aaral
- Indiana4 pag-aaral
- Iowa7 pag-aaral
- Kansas5 pag-aaral
- Kentucky6 pag-aaral
- Louisiana3 pag-aaral
- Maine3 pag-aaral
- Maryland11 pag-aaral
- Massachusetts28 pag-aaral
- Michigan8 pag-aaral
- Minnesota9 pag-aaral
- Missouri6 pag-aaral
- Nebraska6 pag-aaral
- New Jersey15 pag-aaral
- New Mexico3 pag-aaral
- New York26 pag-aaral
- North Carolina20 pag-aaral
- Ohio26 pag-aaral
- Oklahoma4 pag-aaral
- Oregon9 pag-aaral
- Pennsylvania15 pag-aaral
- Rhode Island4 pag-aaral
- South Carolina6 pag-aaral
- Tennessee14 pag-aaral
- Texas31 pag-aaral
- Utah4 pag-aaral
- Vermont4 pag-aaral
- Virginia7 pag-aaral
- Washington11 pag-aaral
- Wisconsin13 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT00923507Rutgers University Study of the Genetics of Blood Cancers
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07714044Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Nagre-recruitPhase 3
Edad 18 hanggang 71 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07504458Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
Nagre-recruitPhase 2
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05645718Natural History Study of GATA2 Deficiency and Related Disorders
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 2 hanggang 100 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT01905826Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)
Nagre-recruitPhase 1
Hanggang edad 75 · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06345027Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT06824168A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Nagre-recruitPhase 1/2
30 Days · Lahat ng kasarian · Na-update Set 16, 2026 · NCT04065399A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
Nagre-recruitPhase 1
Hanggang edad 25 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06810583(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06229912Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06907797Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Nagre-recruitPhase 3
Edad 18 hanggang 18 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07509151Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07249346Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Nagre-recruitPhase 2
Edad 1 hanggang 18 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07354074First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07586618Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
Nagre-recruitPhase 1
Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06408194Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 5 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT05237986Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07284433CIML NK Cells With Venetoclax for AML
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06152809Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
Nagre-recruitPhase 1
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT07439211Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
Nagre-recruitPhase 1
18 Months – 39 Years · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07573111Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Nagre-recruit
Edad 19 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04898790Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.